Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Clemmer Insider Profile
4 Followers
James Clemmer, SVP at Covidien, holds 681.58K shares in AngioDynamics (Ticker: ANGO), holds 62.08K shares in Lantheus (Ticker: LNTH), holds 0.00 shares in Covidien (Ticker: COV). Most recently, James Clemmer Bought ― shares of AngioDynamics on Oct 08, 2024 for an estimated value of 120.60K.
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
+25.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James Clemmer holds in companies
Most Profitable Insider Trade
The most profitable trade made by James Clemmer
James Clemmer's Trading History
Covidien
Jan 28, 2015
―
Uninformative Sell
―
―
Lantheus
Mar 05, 2020
Director
Uninformative Buy
―
$5.42M
AngioDynamics
Oct 08, 2024
President & CEO, Director
Informative Buy
120.60K
$4.74M
List of latest transactions for each holding click on a transaction to see James Clemmer's performance on stock
You May Also Like
James Clemmer insider profile FAQ
What is the percentage of profitable transactions made by James Clemmer?
The percentage of profitable transactions made by James Clemmer is 57%.
What is the average return per transaction made by James Clemmer?
The average return per transaction made by James Clemmer is 25.60%.
What stocks does James Clemmer hold?
James Clemmer holds: COV, LNTH, ANGO stocks.
What was James Clemmer’s latest transaction?
James Clemmer latest transaction was an Informative Buy of $120.60K.
What was James Clemmer's most profitable transaction?
James Clemmer’s most profitable transaction was an Informative Buy of ANGO stock on August 3, 2020. The return on the trade was 225.90%.
What is James Clemmer's role in Covidien?
James Clemmer's role in Covidien is SVP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.